IXC 2.86% 7.2¢ invex therapeutics ltd

Ann: Invex Granted Key European Patent for Exenatide, page-46

  1. 795 Posts.
    lightbulb Created with Sketch. 45
    Im genuinely confused at the share price for the same reasons. Either we are missing something big (legal issue, drug doesnt work, fraud) or this really is one of the golden missed opportunities. Everything is shaping up nicely and as you said this can be a long play or a short play, could sell it for $3 or wait for buyout in the $6 to $30 range.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.701K 23.62K

Buyers (Bids)

No. Vol. Price($)
2 76375 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.